A META-ANALYSIS OF BEMPEDOIC ACID FOR DYSLIPIDEMIA IN STATIN-INTOLERANT PATIENTS
2020
There is lack of evidence for the treatment of statin intolerant patients with dyslipidemia. We aimed to study the safety and efficacy of bempedoic acid (BPA) in this population.
Pubmed, Embase, Scopus and Cochrane library were searched for randomized controlled trials in adults with dyslipidemia
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI